AXSM
179.27 USD
-1.13%
Today
-0.41%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Axsome Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
8.01B
Avg Daily Volume
589.90K
52 Week High
191.5 USD
52 Week Low
86.99 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT1A agonist indicated for the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea; and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, a rapidly absorbed, multi-mechanistic, selective COX-2 inhibitor, and 5-HT1B/1D agonist indicated for the acute treatment of migraine with or without aura. It also develops AXS-05 (dextromethorphan-bupropion), an investigational N-methyl-D-aspartate receptor antagonist, which has completed Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-12 (reboxetine), a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator, which has completed Phase II trial to treat narcolepsy; AXS-14 (esreboxetine), a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, which is in Phase III trial for treating attention deficit hyperactivity, major depressive, binge eating, and excessive sleepiness associated with shift work disorder. It has a research collaboration agreement with Duke University for evaluating AXS-05 in a Phase 2 clinical trial in smoking cessation treatment. The company was incorporated in 2012 and is based in New York, New York.
Top News
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
tradingview.com
2d ago
Alkermes
-4.49%
AveryDennison
-1.54%
Axsome
-0.41%
Blackstone
-1.66%
BeyondMeat
+0.00%
ConAgra
-2.19%
Cal-Maine
-2.38%
CBREGroup
-0.86%
ConocoPhil
-0.24%
Chevron
-0.53%
Deere
-1.20%
WaltDisney
-0.46%
Eaton
+0.80%
Freeport_Mcmoran
+2.43%
Hasbro
-1.50%
Honeywell
-0.45%
Howmet
-0.41%
Intel
+1.02%
EliLilly
-1.75%
Intuitive.Machines
+6.70%
Merit.Medical
-1.31%
Altria
-0.01%
MicronTech
-0.08%
nCino
-1.42%
NewmontM
+2.35%
NIKE
-3.01%
RealtyIncome
+0.93%
Ocugen
-6.99%
Occidental
+0.00%
PackagingAmerica
-0.83%
PhilipMorr
-0.49%
Quanta
+0.66%
RestorationHardware
+1.24%
Rivian_Automotive
+1.25%
SouthernCopper
+2.32%
SnapInc
-2.44%
SanDisk.Corp
+0.16%
Seagate
+0.14%
Tempus.AI
-2.73%
Terex
-2.08%
WesternDig
+1.64%
Beyond.Air
-3.95%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
reuters.com
1w ago
Alkermes
-4.49%
Axsome
-0.41%
Blackstone
-1.66%
BeyondMeat
+0.00%
ConAgra
-2.19%
Cal-Maine
-2.38%
CBREGroup
-0.86%
ConocoPhil
-0.24%
Chevron
-0.53%
Deere
-1.20%
WaltDisney
-0.46%
Freeport_Mcmoran
+2.43%
Hasbro
-1.50%
Honeywell
-0.45%
MicronTech
-0.08%
nCino
-1.42%
NewmontM
+2.35%
NIKE
-3.01%
RealtyIncome
+0.93%
Ocugen
-6.99%
Occidental
+0.00%
Quanta
+0.66%
RestorationHardware
+1.24%
Rivian_Automotive
+1.25%
SouthernCopper
+2.32%
SnapInc
-2.44%
SanDisk.Corp
+0.16%
Seagate
+0.14%
Terex
-2.08%
WesternDig
+1.64%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-Cal-Maine, Rivian, Alkermes
reuters.com
1w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
